Intercept Pharmaceuticals Inc RPE
Was ist das RPE von Intercept Pharmaceuticals Inc?
RPE von Intercept Pharmaceuticals Inc ist $572.411k
Was ist die Definition von RPE?
Umsatz pro Mitarbeiter (RPE) ist der Umsatz geteilt durch die Anzahl der Mitarbeiter einer Organisation.
RPE von Unternehmen in Health Care Sektor auf NASDAQ im Vergleich zu Intercept Pharmaceuticals Inc
Was macht Intercept Pharmaceuticals Inc?
we are a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive, non-viral liver diseases, including primary biliary cholangitis (pbc), nonalcoholic steatohepatitis (nash), primary sclerosing cholangitis (psc) and biliary atresia. in a new age of liver disease treatment, our team is developing vital therapies to meet the needs of those living with progressive, non-viral liver disease. we are committed to improving patients’ lives and addressing the liver community’s most pressing needs. our corporate headquarters is located in new york, and we have additional offices in san diego, london and perugia. for more information about intercept, please visit our website at: www.interceptpharma.com and follow us on twitter at: @interceptpharma.
Unternehmen mit rpe ähnlich Intercept Pharmaceuticals Inc
- Credit Suisse AG hat RPE von CHF571.932k
- Avery Dennison hat RPE von $571.959k
- Tejon Ranch Co hat RPE von $572.043k
- REA hat RPE von AUD$572.160k
- Banco Bilbao Vizcaya Argentaria S.A hat RPE von €572.189k
- Ryder System hat RPE von $572.291k
- Intercept Pharmaceuticals Inc hat RPE von $572.411k
- Shinelong Automotive hat RPE von ¥572.799k
- Ranpak Corp hat RPE von $572.924k
- Five Below Inc hat RPE von $572.938k
- Atari SA hat RPE von €573.077k
- Enterprise Services hat RPE von $573.112k
- Commonwealth Bank of Australia hat RPE von AUD$573.116k